First new drug in 30 years to slow kidney disease in type 1 diabetes ...

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also known as "zombie cells" – in diabetic kidney ...

The nonsteroidal mineralocorticoid receptor antagonist finerenone has been reported to improve kidney and cardiovascular outcomes in persons with type 2 diabetes and chronic kidney disease (CKD).

A new study published in the journal of Frontiers in Endocrinology showed that patients with diabetic kidney disease (DKD) benefit greatly from Sodium-glucose cotransporter-2 (SGLT2) ...

Inside the human body, a silent battle rages between diabetes and kidney function, with devastating consequences many never see coming. Recent medical research has uncovered alarming evidence about ...

Kidney disease is a silent killer, and unlike heart disease and cancer, the symptoms often appear very late. Our study from SGPGI Lucknow in 1999 was among the earliest to show that diabetes (which ...

Associate Professor in Microvascular Medicine, Rebecca Foster, explores therapeutic approaches to improve kidney health for ...

A new report suggests that millions of U.S. adults are unaware they may have undiagnosed cardiovascular risk factors that ...

Microalbuminuria (a high albumin level in your urine) is often a marker of diabetic nephropathy (kidney disease). Since microalbuminuria often doesn’t cause symptoms, experts recommend seeing a doctor ...

Diabetes is a condition in which blood sugar is excessively high. It can be managed by checking blood sugar levels regularly and using insulin to lower those levels (or consuming more sugar to raise ...

Chronic kidney disease is a condition wherein the kidneys are damaged and they aren't able to function as usual. Your kidneys ...